Sally Hollis

发表

STRATOS 1 and 2: considerations in clinical trial design for a fully human monoclonal antibody in severe asthma

C. Brightling, R. Panettieri, G. Colice, 2015 .

Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine

E. Keystone, I. McInnes, Sally Hollis, 2012, Annals of the rheumatic diseases.

Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population

C. Strange, F. Trudo, Sally Hollis, 2015, International journal of chronic obstructive pulmonary disease.

Novel methodology to discern predictors of remission and patterns of disease activity over time using rheumatoid arthritis clinical trials data

Ehrenstein, I. Bruce, Jane Worthington, 2018, RMD Open.

Global Initiative for Asthma 2016–derived asthma control with fluticasone propionate and salmeterol

W. Busse, J. Bousquet, E. Bateman, 2019, Annals of Allergy, Asthma & Immunology.

Prediction of cardiac risk before abdominal aortic reconstruction: comparison of a revised Goldman Cardiac Risk Index and radioisotope ejection fraction.

C. Karkos, Sally Hollis, R. Hughes, 2002, Journal of vascular surgery.

RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients

Francisco Bonachela Capdevila, I. Bruce, Jane Worthington, 2022, Scientific Data.

Preclinical and clinical investigation of a CCR5 antagonist, AZD5672, in patients with rheumatoid arthritis receiving methotrexate.

M. Braddock, P. Tak, J. Vencovský, 2010, Arthritis and rheumatism.

The RA-MAP Consortium: a working model for academia–industry collaboration

Denny Verbeeck, John D. Isaacs, Michael R. Barnes, 2018, Nature Reviews Rheumatology.

Corrigendum: The RA-MAP Consortium: a working model for academia–industry collaboration

D. Symmons, M. Barnes, A. Rowe, 2018, Nature Reviews Rheumatology.

Protecting patient privacy when sharing patient-level data from clinical trials

Janice Branson, M. Dilleen, J. Branson, 2016, BMC Medical Research Methodology.

Data sharing and the evolving role of statisticians

A. Scrimgeour, M. Sydes, H. Burger, 2016, BMC Medical Research Methodology.

Health Care Utilization and Costs After Initiating Budesonide/Formoterol Combination or Fluticasone/Salmeterol Combination Among COPD Patients New to ICS/LABA Treatment

C. Strange, F. Trudo, Sally Hollis, 2016, Journal of managed care & specialty pharmacy.

Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study

C. Strange, F. Trudo, Sally Hollis, 2015, Respiratory Research.

Best practice for analysis of shared clinical trial data

Sally Hollis, Christine Fletcher, Frances Lynn, 2016, BMC Medical Research Methodology.

GINA 2016-derived asthma control with fluticasone propionate/salmeterol: a Gaining Optimal Asthma controL (GOAL) study reanalysis.

W. Busse, J. Bousquet, E. Bateman, 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.